CareDx (CDNA) Research & Development (2013 - 2026)

CareDx (CDNA) has 14 years of Research & Development data on file, last reported at $21.4 million in Q1 2026.

• Quarterly Research & Development rose 15.61% year-over-year to $21.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $74.3 million (up 2.76% YoY) and the FY2025 annual result came in at $71.4 million, down 1.49% from the prior year.
• Research & Development rose to $21.4 million in Q1 2026 per CDNA's latest filing, from $19.3 million in the prior quarter.
• The five-year high for Research & Development was $24.4 million in Q1 2023, with the low at $16.6 million in Q4 2024.
• Average Research & Development over 5 years is $19.9 million, with a median of $19.3 million recorded in 2025.
• Year-over-year, Research & Development jumped 36.72% in 2022 and slipped 23.18% in 2024.
• CareDx's Research & Development stood at $23.6 million in 2022, then slipped by 20.11% to $18.8 million in 2023, then fell by 11.74% to $16.6 million in 2024, then increased by 16.16% to $19.3 million in 2025, then grew by 10.93% to $21.4 million in 2026.
• Business Quant data shows CDNA's Research & Development at $21.4 million in Q1 2026, $19.3 million in Q4 2025, and $16.8 million in Q3 2025.